[go: up one dir, main page]

GB645180A - Improvements in or relating to the conditioning of penicillin - Google Patents

Improvements in or relating to the conditioning of penicillin

Info

Publication number
GB645180A
GB645180A GB24455/48A GB2445548A GB645180A GB 645180 A GB645180 A GB 645180A GB 24455/48 A GB24455/48 A GB 24455/48A GB 2445548 A GB2445548 A GB 2445548A GB 645180 A GB645180 A GB 645180A
Authority
GB
United Kingdom
Prior art keywords
per cent
penicillin
solution
pyrophosphate
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB24455/48A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc SA
Original Assignee
Rhone Poulenc SA
Societe des Usines Chimiques Rhone Poulenc SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc SA, Societe des Usines Chimiques Rhone Poulenc SA filed Critical Rhone Poulenc SA
Publication of GB645180A publication Critical patent/GB645180A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Penicillin is stabilized by admixture with 1 to 10 per cent by weight of an alkali metal phosphate or pyrophosphate or a mixture thereof, which in aqueous solution has a pH 7.0 to 9.0. Preferred mixtures are (a) mono-and di-sodium phosphates containing between 10 and 50 per cent mono-sodium phosphate, and (b) normal and acid sodium pyrophosphate containing 5 to 40 per cent of the acid pyrophosphate. The penicillin is mixed with the dry salt in a sterile container and diluted with sterile water, glucose or saline solutions prior to use.ALSO:A method of producing stable penicillin preparations for injection in aqueous solution comprises introducing into a receptacle a solution of a buffer salt, evaporating such solution to dryness, dry-sterilizing the said receptacle and its contents and introducing solid penicillin into the sterile receptacle. When dissolved in sterile water, saline or glucose solution, the solution is stable within the normal limits of use, e.g. 4 days. To ensure complete sterility of bottles and the removal of pyrogens, the bottles must be subjected to dry heat at 250 DEG C for 1 hour. Such sterilization precludes the use of buffers such as alkali metal citrates which decompose but may be carried out with alkali metal phosphates or pyrophosphates or mixtures thereof, which give aqueous solutions of pH 7.0 to 9.0. Preferred mixtures are (a) mono- and di-sodium phosphates containing between 10 and 50 per cent of monosodium phosphate and (b) normal and acid sodium pyrophosphates containing between 5 and 40 per cent of the acid pyrophosphate. The mixtures are used in the proportion of 1 to 10 per cent of the weight of the penicillin stabilized.
GB24455/48A 1948-05-13 1948-09-17 Improvements in or relating to the conditioning of penicillin Expired GB645180A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR645180X 1948-05-13

Publications (1)

Publication Number Publication Date
GB645180A true GB645180A (en) 1950-10-25

Family

ID=9000582

Family Applications (1)

Application Number Title Priority Date Filing Date
GB24455/48A Expired GB645180A (en) 1948-05-13 1948-09-17 Improvements in or relating to the conditioning of penicillin

Country Status (1)

Country Link
GB (1) GB645180A (en)

Similar Documents

Publication Publication Date Title
Gordon Properties of brain pyrophosphatase
GB1072827A (en) New perhydrates of phosphonic acids containing nitrogen
GB645180A (en) Improvements in or relating to the conditioning of penicillin
GB833568A (en) Improvements in or relating to detergent compositions and processes for the manufacture thereof
Lundin Acetylcholinesterase in goldfish muscles. Studies on some substrates and inhibitors
GB1340404A (en) Sodium tripolyphosphate
US2834710A (en) Pancreatic desoxyribonuclease penicillin composition and process of preparation
GB716539A (en) Dust-laying process
GB1087003A (en) Stabilization of phosphoric acid esters
GB886217A (en) Process for the manufacture of reaction products from phosphoric acid and sodium carbonate
GB715976A (en) Improvements in medical preparations for removing toxic heavy metals from the human body
GB643268A (en) Improved process for the preparation of prolonged effect insulin products
GB728688A (en) Process for the stabilisation of adenosine polyphosphoric acids
GB446529A (en) Improvements in or relating to the treatment of milk and milk preparations
GB613080A (en) Improvements in the preparation of stable medicinal salts of acetylsalicylic acid
NL32365C (en)
PĂ©ron et al. Cyclic AMP response of isolated Snell adrenocortical carcinoma 494 cells to trophic hormones and other substances
GB798782A (en) Anhydrous sterile preparations of alkali barbiturates and alkali thiobarbiturates
GB813960A (en) An improved clinical dextran and method for producing the same
JPS5697222A (en) Injectable aqueous solutions and their manufacture
ES8206533A1 (en) Water soluble derivatives of cephalexin and process for their preparation.
GB748823A (en) Improvements in or relating to hair treating preparations
GB793255A (en) Detergent compositions
GB805942A (en) Improvements relating to the preparation of urea crystals
GB730929A (en) Stabilised aqueous hyaluronidase solutions and method of preparing them